Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant neoplasm of stomach
|
615 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.020 | 1.000 | 2 | 2016 | 2017 | |||||
Malignant Neoplasms
|
1641 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.020 | 1.000 | 2 | 2017 | 2017 | |||||
Primary malignant neoplasm
|
1374 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.020 | 1.000 | 2 | 2017 | 2017 | |||||
Squamous cell carcinoma of esophagus
|
329 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.020 | 1.000 | 2 | 2012 | 2016 | |||||
Stomach Carcinoma
|
652 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.020 | 1.000 | 2 | 2016 | 2017 | |||||
Xeroderma pigmentosum, group G
|
31 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.020 | 1.000 | 2 | 2016 | 2017 | |||||
Breast Carcinoma
|
2793 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Carcinoma of lung
|
1204 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Central neuroblastoma
|
231 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Childhood Neuroblastoma
|
231 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Colorectal Carcinoma
|
1962 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Esophageal carcinoma
|
272 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Esophageal Neoplasms
|
270 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Fibroid Tumor
|
14 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Gastritis, Atrophic
|
61 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Giant Cell Arteritis
|
78 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1 | 2016 | 2016 | ||||||
Liver carcinoma
|
942 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant neoplasm of breast
|
3417 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Malignant neoplasm of esophagus
|
214 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Malignant neoplasm of lung
|
1142 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Myoma
|
4 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Neoplasms
|
1644 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Neuroblastoma
|
386 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Primary malignant neoplasm of lung
|
981 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Uterine Fibroids
|
154 | 0.677 | 0.360 | 13 | 102875987 | 3 prime UTR variant | G/A | snv | 0.59 | 0.010 | 1.000 | 1 | 2018 | 2018 |